tupungato/iStock via Getty Images
- iBio (NYSE:IBIO) filed for a mixed shelf offering with the SEC up to a maximum aggregate offering price of $150M.
- The offering can include common stock, preferred stock, various series of debt securities and/or warrants to purchase any of such securities, either individually or as units in combination.
- The company intends to use the net proceeds from the sale of the securities offered by us hereunder primarily for working capital and general corporate purposes.
- Source: Form S-3